These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32838438)

  • 1. Establishment of Clinical and Lab Algorithms for the Identification of Carriers of Mutations in CYP21A2 - A Study of 365 Children and Adolescents.
    Meinel J; Haverkamp T; Wünsche F; Richter-Unruh A
    Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):492-499. PubMed ID: 32838438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
    Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal levels of 17-hydroxyprogesterone can distinguish children with isolated precocious pubarche.
    Grandone A; Marzuillo P; Luongo C; Toraldo R; Mariani M; Miraglia Del Giudice E; Perrone L
    Pediatr Res; 2018 Oct; 84(4):533-536. PubMed ID: 29976972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in hormonal levels between heterozygous
    Silva RS; Carvalho B; Pedro J; Castro-Correia C; Carvalho D; Carvalho F; Fontoura M
    Arch Endocrinol Metab; 2022 Apr; 66(2):168-175. PubMed ID: 35289513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
    Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
    Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
    Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
    Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the ACTH stimulation test in hirsute women.
    Erel CT; Senturk LM; Oral E; Mutlu H; Colgar U; Seyisoglu H; Ertungealp E
    J Reprod Med; 1999 Mar; 44(3):247-52. PubMed ID: 10202742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
    Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
    Sahlander F; Bensing S; Falhammar H
    Front Endocrinol (Lausanne); 2022; 13():1017303. PubMed ID: 36545328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency.
    Liu E; Luo H; Zhou K; Zhang Y
    Arch Gynecol Obstet; 2023 Sep; 308(3):871-882. PubMed ID: 36773044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kang MJ; Kim SM; Lee YA; Shin CH; Yang SW
    J Korean Med Sci; 2011 Nov; 26(11):1454-60. PubMed ID: 22065901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
    Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.